The provided materials describe multiple federal contract Indefinite Delivery Vehicles (IDVs) and associated task orders awarded to Abbott Laboratories Inc., a global healthcare company, by various civilian federal agencies including the Department of Veterans Affairs (VA), Indian Health Service (IHS), and Department of Health and Human Services. The key products and services being delivered under these contracts include a range of in-vitro diagnostic equipment, reagents, test kits, and related supplies to support clinical testing and healthcare operations across government healthcare systems. The contract vehicles, primarily Blanket Purchase Agreements established under Abbott's existing GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits, facilitate streamlined procurement of critical point-of-care testing devices, such as the Abbott i-STAT analyzer and cartridges, as well as other specialty medical equipment and consumables. The contracts, which do not utilize any small business set-asides, have a total combined ceiling value exceeding $100 million and support the VA, IHS, and other federal agencies in delivering quality healthcare services to veteran, Native American, and other patient populations. The period of performance for these IDVs and task orders ranges from 2023 through 2029, ensuring continued access to essential diagnostic products and related services.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00013 | Other Administrative Action | $0 | 6/23/25 | |
| P00011 | Supplemental Agreement for work within scope | $0 | 3/31/25 | |
| P00010 | Add Subcontract Plan | $0 | 1/30/25 | |
| P00009 | Supplemental Agreement for work within scope | $0 | 6/4/24 | |
| P00008 | Supplemental Agreement for work within scope | $0 | 5/1/24 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Last Date To Order (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
36F79721D0233-36C25624A0002 | Abbott Laboratories Inc. | $4.7m | 5/1/24 | 4/30/29 | 4/30/25 | |
36F79721D0233-36C26323A0037 | Abbott Laboratories Inc. | $521.4k | 10/1/23 | 9/30/25 | 6/9/25 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36F79721D0233-75H70723F80016 | Abbott Laboratories Inc. | $223.7k | 1/14/23 | 2/28/26 | 12/6/24 | |
BPA Call 36C26323A0037-36C26325N0113 | Abbott Laboratories Inc. | $169.6k | 10/1/24 | 9/30/25 | 10/3/24 | |
Delivery Order 36F79721D0233-36C24823F0137 | Abbott Laboratories Inc. | $384.3k | 4/1/23 | 9/30/23 | 3/10/25 | |
BPA Call 36C26323A0037-36C26325N0111 | Abbott Laboratories Inc. | $22.6k | 10/1/24 | 9/30/25 | 10/1/24 | |
BPA Call 36C25624A0002-36C25625N0106 | Abbott Laboratories Inc. | $644.6k | 10/1/24 | 9/30/25 | 10/1/24 |
Name | Description | Size | Type (Click to sort descending) | Posted (Click to sort descending) |
|---|---|---|---|---|
FSS-65-VII - Abbott Laboratories Inc. - 36F79721D0233 | 313KB | Not listed |